Kinnari Patel
President at ROCKET PHARMACEUTICALS, INC.
Net worth: 10 M $ as of 2024-03-30
Profile
Kinnari Patel's current job is as the President, Chief Operating Officer, and Head of R&D at Rocket Pharmaceuticals, Inc. He started this position in 2024.
Dr. Patel's former jobs include being the Head of US Risk Management at Bristol Myers Squibb Co. from 2010 to 2014, and the Chief Operating Officer & Head of Development at Rocket Pharmaceuticals Ltd.
from 2016 to 2021.
Dr. Patel's education history includes an undergraduate and doctorate degree from the University of the Sciences in Philadelphia, as well as an MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-15 | 378,903 ( 0.42% ) | 10 M $ | 2024-03-30 |
Kinnari Patel active positions
| Companies | Position | Start |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | President | - |
Former positions of Kinnari Patel
| Companies | Position | End |
|---|---|---|
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Chief Operating Officer | 2021-01-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2014-03-31 |
Training of Kinnari Patel
| University of the Sciences in Philadelphia | Doctorate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Kinnari Patel
